97 related articles for article (PubMed ID: 12773479)
1. Binding of the CC-chemokine RANTES to syndecan-1 and syndecan-4 expressed on HeLa cells.
Slimani H; Charnaux N; Mbemba E; Saffar L; Vassy R; Vita C; Gattegno L
Glycobiology; 2003 Sep; 13(9):623-34. PubMed ID: 12773479
[TBL] [Abstract][Full Text] [Related]
2. RANTES (CCL5) induces a CCR5-dependent accelerated shedding of syndecan-1 (CD138) and syndecan-4 from HeLa cells and forms complexes with the shed ectodomains of these proteoglycans as well as with those of CD44.
Charnaux N; Brule S; Chaigneau T; Saffar L; Sutton A; Hamon M; Prost C; Lievre N; Vita C; Gattegno L
Glycobiology; 2005 Feb; 15(2):119-30. PubMed ID: 15355933
[TBL] [Abstract][Full Text] [Related]
3. A syndecan-4/CXCR4 complex expressed on human primary lymphocytes and macrophages and HeLa cell line binds the CXC chemokine stromal cell-derived factor-1 (SDF-1).
Hamon M; Mbemba E; Charnaux N; Slimani H; Brule S; Saffar L; Vassy R; Prost C; Lievre N; Starzec A; Gattegno L
Glycobiology; 2004 Apr; 14(4):311-23. PubMed ID: 15033938
[TBL] [Abstract][Full Text] [Related]
4. Interaction of RANTES with syndecan-1 and syndecan-4 expressed by human primary macrophages.
Slimani H; Charnaux N; Mbemba E; Saffar L; Vassy R; Vita C; Gattegno L
Biochim Biophys Acta; 2003 Oct; 1617(1-2):80-8. PubMed ID: 14637022
[TBL] [Abstract][Full Text] [Related]
5. Syndecan-4 is a signaling molecule for stromal cell-derived factor-1 (SDF-1)/ CXCL12.
Charnaux N; Brule S; Hamon M; Chaigneau T; Saffar L; Prost C; Lievre N; Gattegno L
FEBS J; 2005 Apr; 272(8):1937-51. PubMed ID: 15819887
[TBL] [Abstract][Full Text] [Related]
6. The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9.
Brule S; Charnaux N; Sutton A; Ledoux D; Chaigneau T; Saffar L; Gattegno L
Glycobiology; 2006 Jun; 16(6):488-501. PubMed ID: 16513763
[TBL] [Abstract][Full Text] [Related]
7. I-TAC/CXCL11 is a natural antagonist for CCR5.
Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B
J Leukoc Biol; 2004 Sep; 76(3):701-8. PubMed ID: 15178708
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactivity to cell surface syndecans in cytoplasm and nucleus: tubulin-dependent rearrangements.
Brockstedt U; Dobra K; Nurminen M; Hjerpe A
Exp Cell Res; 2002 Apr; 274(2):235-45. PubMed ID: 11900484
[TBL] [Abstract][Full Text] [Related]
9. Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5.
Nattermann J; Nischalke HD; Feldmann G; Ahlenstiel G; Sauerbruch T; Spengler U
J Viral Hepat; 2004 Nov; 11(6):519-26. PubMed ID: 15500552
[TBL] [Abstract][Full Text] [Related]
10. RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans.
Suffee N; Hlawaty H; Meddahi-Pelle A; Maillard L; Louedec L; Haddad O; Martin L; Laguillier C; Richard B; Oudar O; Letourneur D; Charnaux N; Sutton A
Angiogenesis; 2012 Dec; 15(4):727-44. PubMed ID: 22752444
[TBL] [Abstract][Full Text] [Related]
11. Multiple pathways of amino terminal processing produce two truncated variants of RANTES/CCL5.
Lim JK; Burns JM; Lu W; DeVico AL
J Leukoc Biol; 2005 Aug; 78(2):442-52. PubMed ID: 15923218
[TBL] [Abstract][Full Text] [Related]
12. Recognition of RANTES by extracellular parts of the CCR5 receptor.
Duma L; Häussinger D; Rogowski M; Lusso P; Grzesiek S
J Mol Biol; 2007 Jan; 365(4):1063-75. PubMed ID: 17101151
[TBL] [Abstract][Full Text] [Related]
13. A model for non-viral gene delivery: through syndecan adhesion molecules and powered by actin.
Kopatz I; Remy JS; Behr JP
J Gene Med; 2004 Jul; 6(7):769-76. PubMed ID: 15241784
[TBL] [Abstract][Full Text] [Related]
14. Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells.
Charni F; Friand V; Haddad O; Hlawaty H; Martin L; Vassy R; Oudar O; Gattegno L; Charnaux N; Sutton A
Biochim Biophys Acta; 2009 Oct; 1790(10):1314-26. PubMed ID: 19632304
[TBL] [Abstract][Full Text] [Related]
15. Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro.
Maeda K; Nakata H; Koh Y; Miyakawa T; Ogata H; Takaoka Y; Shibayama S; Sagawa K; Fukushima D; Moravek J; Koyanagi Y; Mitsuya H
J Virol; 2004 Aug; 78(16):8654-62. PubMed ID: 15280474
[TBL] [Abstract][Full Text] [Related]
16. pH-independent endocytic cycling of the chemokine receptor CCR5.
Signoret N; Christophe T; Oppermann M; Marsh M
Traffic; 2004 Jul; 5(7):529-43. PubMed ID: 15180829
[TBL] [Abstract][Full Text] [Related]
17. Syndecan-4-dependent migration of human eosinophils.
Feistritzer C; Kaneider NC; Sturn DH; Wiedermann CJ
Clin Exp Allergy; 2004 May; 34(5):696-703. PubMed ID: 15144459
[TBL] [Abstract][Full Text] [Related]
18. Analyzing ligand and small molecule binding activity of solubilized GPCRs using biosensor technology.
Navratilova I; Dioszegi M; Myszka DG
Anal Biochem; 2006 Aug; 355(1):132-9. PubMed ID: 16762304
[TBL] [Abstract][Full Text] [Related]
19. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A
Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698
[TBL] [Abstract][Full Text] [Related]
20. Large-scale expression and purification of the major HIV-1 coreceptor CCR5 and characterization of its interaction with RANTES.
Nisius L; Rogowski M; Vangelista L; Grzesiek S
Protein Expr Purif; 2008 Oct; 61(2):155-62. PubMed ID: 18588983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
